Skip to main content

Find Clinical Trials

Home
Conditions
Pharyngeal Diseases

Clinical trial condition

Pharyngeal Diseases

Explore clinical trials studying Pharyngeal Diseases. Study availability and eligibility vary by location and protocol.

1,560 public trials 361 recruiting studies

Refine in advanced search Browse all conditions

Pharyngeal Diseases trial results

Active, Not Recruiting

Translation and Validation of a Swallowing Assessment Scale for Neurogenic Dysphagia

NCT07503145

Conditions: Deglutition Disorders, Digestive System Diseases, Dysphagia, +4 more
Locations: IRCCS San Camillo Lido, VE, Italy

View Trial Details

Active, Not Recruiting

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

NCT06167291

Conditions: Head and Neck Neoplasms, Lymphoscintigraphy, Neoplasms, +8 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia

NCT02838316

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: UC Davis Medical Center, Department of Otolaryngology, Head and Neck Surgery Sacramento, California, United States

View Trial Details

Active, Not Recruiting

A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

NCT06118333

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia

NCT01266044

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Mouth Diseases, +10 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

Fudan University Cancer Hospital Shanghai, China

View Trial Details

Active, Not Recruiting

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

NCT05232851

Conditions: Carcinoma, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Neoplasms, +14 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

NCT02945631

Conditions: Head and Neck Neoplasms, Locally Advanced HPV Positive Oropharynx Cancer, Neoplasms, +7 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, Not Recruiting

Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer

NCT05387915

Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Neoplasms, Neoplasms, +8 more
Locations: Emory University Midtown Hospital Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

NCT01898494

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +28 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View all 58 locations

View Trial Details

Active, Not Recruiting

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

NCT02287311

Conditions: Carcinoma, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, +25 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details